Global Alpha Sells $17.9 Million Worth of Ani Pharmaceuticals Shares
On May 11, 2026, Global Alpha Capital Management Ltd reported selling 228,895 shares of ANI Pharmaceuticals (ANIP) for an estimated value of $17.87 million in Q1 2026 trading activity. The position's quarter-end valuation dropped by $18.81 million due to both share price movements and the sale itself.
Tickers: $ANIP
Topics: 13F filing institutional trading stock position reduction